Joseph McClellan
Net worth: 517 568 $ as of 31/05/2026
Net worth: 517 568 $ as of 31/05/2026
Joseph E.
McClellan is Chief Scientific Officer at Alvotech hf since 2019.
Dr. McClellan is Chief Operating Officer at Alvotech starting in 2025.
Formerly, Dr. McClellan was Global Head-Biosimilars Development & Medicine at Pfizer Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), a doctorate from the University of Florida, and an MBA from Northeastern University (China).
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ALVOTECH 0.05% | 06/03/2026 | 154,038 ( 0.05% ) | 517 568 $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| ALVOTECH | Chief Operating Officer | 12/11/2025 |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Chief Tech/Sci/R&D Officer | 01/10/2019 |
| Companies | Position | End |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University (China)
Northeastern University (China) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Alvotech
Alvotech BiotechnologyHealth Technology Develops biologic medicines | Health Technology |
Select your edition
All financial news and data tailored to specific country editions